Healthcare Finance

Add to Favourites
1 1 1 1 1
Price: 1322 EUR 1322 EUR
Contact Massachusetts Institute of Technology

More details about the program

Description

Funding for fundamental science and early-stage translational medicine is becoming scarcer, and at the worst possible time—when we now have the scientific and engineering expertise to make major breakthroughs in our understanding of the molecular basis of many deadly diseases and how to treat or prevent them. The dearth of funding for translational medicine in the so-called “Valley of Death” can be attributed to several factors, but a common thread among them is increasing financial risks in the biopharma industry and greater uncertainty surrounding the economic, regulatory, and political environments within the biomedical ecosystem. Increasing risk and uncertainty inevitably leads to an outflow of capital as investors and other stakeholders seek more attractive opportunities in other industries.By applying financial techniques such as portfolio theory, securitization, and option pricing to biomedical contexts, more efficient funding structures can be developed to reduce financial risks, lower the cost of capital, and bring more life-saving therapies to patients faster. By taking this course, students will gain the background, resources, and framework to influence the healthcare industry.Image used under license from Shutterstock.com

Specific details

Category of Education Medicine and Healthcare

Comments (0)

There are no comments posted here yet

Leave your comments

Search

Related Programs

In contemporary societies healthcare is a key soci ...
The purpose of this course is to introduce student ...
This course offers an intimate, story-based introd ...
Our society depends on the availability of food an ...

 

©2023 EDUCOM NET. All Rights Reserved.

If you find an inaccuracy or you have comments on the description of the university or program - please let us know info@educom.net